Abera Bioscience AB Employee Directory
Biotechnology ResearchUppsala, Sweden11-50 Employees
Abera Bioscience AB is a Swedish biotechnology company focused on developing vaccines that protect mucosal surfaces to improve global health. Through its proprietary platforms, the company aims to create multivalent, multi-stage vaccines for oral and nasal administration and to enable faster, more cost-effective production, with nasal vaccines able to be manufactured in roughly two weeks to a month. The company is based in Uppsala, Sweden, and maintains a relatively small to mid-sized team. Within the biotechnology research sector, Abera concentrates on mucosal vaccine approaches intended to confront respiratory viruses and potential pandemics. In December 2024, Abera announced a collaboration with Orexo to develop nasal powder vaccines for prevention of disease and transmission.
1-888-653-2347 
support@leadiq.com 
